Neurons

Predictive creative testing software based on neuroscience data.

Available information varies by company and source.

Profile record updated:

Company facts

Official name
Neurons Inc
Entity type
COMPANY
Founded
2013
Headquarters
Høje Taastrup Boulevard 33, Tåstrup, Capital Region, 2630, DK
Company size
50–200
Market role
AdTech Vendor
Official website
neuronsinc.com

What Neurons does

Neurons operates a B2B SaaS model centred on predictive creative analytics. It uses proprietary neuroscience and eye-tracking training data to produce attention heatmaps, behavioural scores, and optimisation recommendations for ad assets. Value is created by reducing creative testing time, improving campaign readiness before launch, and allowing customers to embed predictive insights into their own workflows through an API.

Category differentiation

This company is not a general-purpose AI model provider or a traditional market research panel business. It specialises in B2B predictive creative analytics based on neuroscience and attention data for advertising use cases.

Strategic context

AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.

Neurons is a Danish B2B software company that provides neuroscience-based creative testing and predictive analytics for advertising assets. Its core platform helps brands, agencies, and insights teams assess likely audience attention, engagement, and memory responses before campaigns go live, using models trained on long-running eye-tracking and brain-response datasets. The business generates revenue primarily from subscription access to its creative intelligence platform, with additional monetisation through enterprise-style API access, add-ons, and services such as workshops. Its customers are mainly advertiser marketing teams, media agencies, and technical analytics teams seeking to pre-test and optimise creative across digital channels without relying solely on live A/B testing.

Company news briefing

Briefing updated:

Neurons has expanded its platform capabilities by launching video and mixed media analysis, incorporating attention tracking and benchmark metrics. The company also enhanced its Visual Recommendations tool with deeper brand integration and more granular exports. Furthermore, the appointment of former Danish Prime Minister Helle Thorning-Schmidt to the board reinforces the organisation’s focus on ethical AI and responsible business practices.

Business model & monetisation

Neurons monetises primarily through tiered SaaS subscriptions for its core platform, with pricing tied to access level, usage, team configuration, and feature entitlements. It also uses add-on revenue from extra users, single sign-on, brand kits, and workshops. Its API likely adds enterprise licensing or usage-linked commercial terms for customers embedding predictive attention data into internal systems or partner products.

Core creative intelligence platform
SaaS subscription tiers
API access
Enterprise licensing or usage-based access
Add-ons and workshops
Service fees and feature upsells

Products & capabilities

No products with linked sources are available in this view.

Products & market categories

Recent recorded signals

Dates refer to the source publication. Older entries are historical context, not evidence of a new event.

Explore company relationships

Questions about Neurons

What is Neurons?

Neurons is a Danish B2B software company that helps advertisers and agencies pre-test and optimise ad creative using predictive neuroscience-based analytics.

Who uses Neurons?

Its users include brand marketing teams, media agencies, insights teams, developers, and analytics teams that evaluate advertising creative before launch.

How does Neurons make money?

It primarily earns revenue from tiered SaaS subscriptions, with additional income from API access, add-ons, and related workshops or enterprise services.

Sources & coverage

This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.

18 publicly documented primary sources and citations linked across the market graph.

Continue your research on Neurons

Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.

Free, with no time limit.